Bellevue Global Life Science Investors LLC
CIK 1953768 · View on SEC EDGAR ↗
Insider
First SEC filing: Feb. 9, 2023 · Latest: Feb. 9, 2023
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 15 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
15 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2023 | OSRHW | P | 430,000 | $10.00 | $4,300,000 | 430,000 Direct | — | Acquired | -99.7% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 23, 2023 | OSRHW | Warrant for Common Stock | Common Stock (20,000) | $11.50 | — | 20,000 | Disposed |
| Feb. 14, 2023 | OSRHW | Warrant for Common Stock | Common Stock (20,000) | $11.50 | — | 20,000 | Disposed |
| Feb. 14, 2023 | OSRHW | Warrant for Common Stock | Common Stock (20,000) | $11.50 | — | 20,000 | Disposed |
| Feb. 14, 2023 | OSRHW | Private Placement Warrants | Common Stock (430,000) | $11.50 | — | 430,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 9, 2023 | OSRHW | Common Stock | 1,725,000 | Direct |